Laporan Kasus Stemi
Laporan Kasus Stemi
Laporan Kasus Stemi
CASE REPORT:
ST SEGMENT ELEVATION
INFERIOR MYOCARDIAL INFARCTION
ONSET > 24 HOURS KILLIP II
Presented by:
Nurhafidah Mahfudz C111 12 058
Andi Saputri Majid C111 12 057
Andi Idil Saputra C111 12 059
Hartati Hamzi C111 12 062
Supervisor:
dr. Abdul Hakim, Sp.JP, FIHA
PATIENT IDENTITY
Name : Mr. B
Age : 61 years old
Address : Mattoanging
MR : 532990
Date of Admission : 19/4/2016
HISTORY TAKING
DOE (+)
PND (+)
Cor :
Inspection : ictus cordis not visible
Palpation : ictus cordis is palpable, thrill (-)
Percussion :
Upper border 2nd ICS sinistra
Abdomen :
Inspection : flat, follows breath movement
Auscultation : peristaltic (+), normal
Palpation : liver and spleen not palpable
Percussion : tympani
Extremities :
Edema (-)
ELECTROCARDIOGRAPHY
Conclusion:
- CTI 0,31 (normal)
- Active pulmonary TB
- Lymphadenopathy hilar dextra
ECHOCARDIOGRAPHY
3. Diastolic Dysfunction
TREATMENT
Lateral
I, AVL,V5-V6
Inferior
II, III, aVF Anterior / Septal
V1-V4
Pathophysiology
RISK FACTORS
Modifiable Non-
Modifiable
CLINICAL PATHWAY
WHO DIAGNOSTIC CRITERIA
*Patients with cardiogenic shock or severe heart failure initially seen at a non–PCI-capable hospital should be transferred for cardiac
catheterization and revascularization as soon as possible, irrespective of time delay from MI onset (Class I, LOE: B). †Angiography and
revascularization should not be performed within the first 2 to 3 hours after administration of fibrinolytic therapy.
- Reperfusion Therapy -
Thrombolitik
ALTEPLASE
50mg iv in 30minutes
35mg iv in 60minutes
TREATMENT
Bisoprolol Clinical Study shows:
-Limit area of MI
Relieve symptom -re-infarction risk decrease
NTG -prolong life span
Vasodilatation
-Plaque stabilization
-LDL decrease
target: <70mg/dl Atorvastatin -Anti-remodelling
-decrease mortality
Captopril
TREATMENT